The purpose of this document is to provide general information about bone scintigraphy in oncology. The corresponding guidelines from the Society of Nuclear Medicine SNM have been taken into consideration, reviewed and partially integrated with this text. Bone scintigraphy is an highly sensitive method for demonstrating disease in bone. Phosphate analogues can be labelled with?99mTc and are used for bone imaging because of their good localisation in the skeleton and rapid clearance from soft tissues.
